https://www.benzinga.com/news/21/10/23512541/35-stocks-moving-in-fridays-mid-day-session
35 Stocks Moving In Friday's Mid-Day Session - Agenus (NASDAQ:AGEN) - Benzinga
https://www.fool.com/earnings/call-transcripts/2021/03/15/agenus-inc-agen-q4-2020-earnings-call-transcript/
Agenus Inc (AGEN) Q4 2020 Earnings Call Transcript | The Motley Fool
Mar 15, 2021 - AGEN earnings call for the period ending December 31, 2020.
earnings call transcriptthe motleyincagen
https://www.prnewswire.com/news-releases/agenus-to-participate-in-a-panel-on-cell-therapy-for-infectious-diseases-at-the-b-riley-virtual-infectious-disease-summit-301097296.html
Agenus To Participate in a Panel on Cell Therapy for Infectious Diseases at the B. Riley Virtual...
/PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies and...
https://www.agenusbio.com/
Agenus: Better immunotherapies
Activating the Power of the Immune System to Defeat Cancer
betterimmunotherapies
https://www.fiercebiotech.com/biotech/agenus-fda-approval-site-showcases-anti-pd-1-drug-data
Agenus, with FDA approval in sight, showcases anti-PD-1 data | Fierce Biotech
Aug 27, 2021 - Agenus is now in the closing stretch of its multidecade effort to bring a drug to market.
https://www.prweb.com/releases/agenus-implements-genedata-end-to-end-biologics-workflow-platform-for-immunotherapy-r-amp-d-810182728.html
Agenus Implements Genedata End-to-End Biologics Workflow Platform for Immunotherapy R&D
https://www.nasdaq.com/market-activity/stocks/agen/analyst-research
Agenus Inc. Common Stock (AGEN) Analyst Research | Nasdaq
Find the latest analyst research, reports, and ratings for Agenus Inc. Common Stock (AGEN) at Nasdaq.com.
common stockanalyst researchincagennasdaq
https://markets.businessinsider.com/news/agenus_3
Agenus News | Markets Insider
Agenus News: This is the News-site for the company Agenus on Markets Insider
newsmarketsinsider
https://www.biopharmadive.com/news/agenus-restructuring-biotech-layoffs-/691608/
Agenus to lay off 25% of staff, trim pipeline in cancer drug push | BioPharma Dive
The job cuts are meant to preserve enough cash so the nearly three-decade-old company can potentially pursue its first drug approval next year.
https://www.globenewswire.com/en/news-release/2024/10/14/2962530/0/en/AGENUS-INC-NASDAQ-AGEN-DEADLINE-ALERT-Bernstein-Liebhard-LLP-Reminds-Agenus-Inc-Investors-of-Upcoming-Deadline.html
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline...
deadline alertincnasdaqagenbernstein